Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Q2 Program Management Update

17 Aug 2020 07:00

RNS Number : 2531W
Randall & Quilter Inv Hldgs Ltd
17 August 2020
 

 

 

Randall & Quilter Investment Holdings Ltd.

 

Q2 Program Management Update

 

17 August 2020

 

Randall & Quilter Investment Holdings Ltd. (AIM-RQIH) ("R&Q"), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, announces a performance update for its Program Management business, for the six months ended 30 June 2020.

 

Highlights

 

· Contracted Premium of $924.5 million (H1 2019: $431.6 million), a 114% increase

 

· Gross Written Premium of $247.2 million (H1 2019: $172.9 million), a 43% increase

 

· Economic Commission Revenue1 of $10.7 million (H1 2019: $5.7 million), an 88% increase

 

· Addition of 10 new programs bringing the total number of active programs to 36 (H1 2019: 26)

 

· Subsequent to the end of Q2 2020, four new programs were signed with Contracted Premium of approximately $200 million, all of which are expected to begin generating Gross Written Premium shortly

 

· Expected to enter the US Excess & Surplus ("E&S") Program Management market in Q4 2020

 

Commenting on the Program Management results, Alan Quilter, Group Chief Executive Officer, said:

 

"In the first half of 2020, our Program Management business, trading under the Accredited banner, continued to grow strongly. Importantly, this business has significant built-in growth through the 36 existing programs and 34 different distribution partners with whom we have secured contracts as of the end of Q2 2020. In addition, the four new programs we signed post the half year, are expected to generate in excess of $200 million of annual recurring Gross Written Premium when they achieve scale over the next 18 months.

 

We continue to see strong demand from new origination partners as existing insurance capacity faces capital challenges given the magnitude of the insured losses from Covid 19. Moreover, due to current market conditions, we expect to enter the US E&S Program Management market, a large addressable market in which we do not presently compete, in Q4 2020, accelerating our original plans. This launch will see Accredited achieve its strategic objective of being a comprehensive program management solutions provider in all its major markets."

 

R&Q will provide a further update on its Program Management business for the nine months ended 30 September 2020 in the fourth quarter.

 

1: Economic Commission Revenue represents the Commission Revenue from insurance policies already bound (written), regardless of the length of the underlying policy period (earned). We believe Economic Commission Revenue is a more appropriate measure of the revenue of the business during periods of high growth, due to larger than normal gap between Gross Written and Gross Earned (IFRS) Premium, and the corresponding fees.

 

 

Ends

Notes to Editors:

 

Randall & Quilter Investment Holdings Ltd.

 

Ken Randall

William Spiegel

 

Tel: +44 (0)7831 145440

Tel: +001 917 826 5877

Numis Securities Limited (Nominated Adviser)

Stuart Skinner / Huw Jeremy

Tel: 020 7260 1000

Charles Farquhar

Tel: 020 7260 1000

 

Shore Capital Stockbrokers Limited

Stephane Auton

James Thomas

Tel: 020 7408 4090

 

FTI Consulting

Edward Berry

Tom Blackwell

 

 

Tel: 020 3727 1046

 

About Accredited

 

Accredited is R&Q's Program Management business. Operating in the US, UK and Europe, Accredited is the only program carrier that has an AM Best A- credit rating in all these markets. In the US Accredited is licensed in all 50 states and in the UK/Europe it is licensed to write all classes of non-life business.

 

Accredited has also established a fully authorised UK branch to facilitate continued access to the large UK market, post Brexit. This branch will get the full benefit of Accredited Malta's A- rating from AM Best.

 

Accredited's (US) Financial Strength Category increased in 2019 to an AM Best category IX making it one of the highest rated program managers in the US and providing an important support for the business' continued growth.

 

About R&Q

 

R&Q is a non-life global specialty insurance company operating two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in markets with high barriers to entry and significant secular growth opportunities.

 

Legacy Insurance generates profits and capital extractions from expert management of legacy non-life insurance portfolios. Program Management generates commission income from its licensed (and rated) carriers in the US, EU and the UK, writing niche and profitable program business, largely on behalf of highly rated reinsurers.

 

For the financial year ended 31 December 2019 R&Q reported pre-tax profits of over £40 million.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website : www.rqih.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDPFMLTMTJBBLM
Date   Source Headline
15th Jul 20208:01 amRNSBonus Share Issue and Total Voting Rights
9th Jul 20201:07 pmRNSResult of AGM
9th Jul 202012:00 pmRNSKen Randall Announces Retirement Date
26th Jun 20207:00 amRNSCaptive Acquisition
24th Jun 20204:41 pmRNSBonus Share Issue Ex-Entitlement Date
16th Jun 20209:31 amRNSDistribution of Annual Report & Accounts
15th Jun 20204:47 pmRNSNotice of Annual General Meeting
8th Jun 20204:36 pmRNSHolding(s) in Company
5th Jun 20207:00 amRNSAcquisition of NationsBuilders Insurance Company
4th Jun 20205:36 pmRNSHolding(s) in Company
4th Jun 20207:00 amRNSLoss Portfolio Transfer
1st Jun 20207:00 amRNSFinal results for the year ended 31 December 2019
29th May 20204:25 pmRNSResult of General Meeting
21st May 20207:00 amRNSAppointment of CFO
13th May 20207:00 amRNSBoard Appointment
7th May 20207:00 amRNSNotice of General Meeting and Posting of Circular
6th May 20203:51 pmRNSHolding(s) in Company
6th May 20207:00 amRNSHolding(s) in Company
6th May 20207:00 amRNSHolding(s) in Company
29th Apr 20207:00 amRNSSignificant new investment in the Group
24th Apr 20202:05 pmRNSTransaction in Own Shares
24th Apr 20207:00 amRNSLoss Portfolio Transfer
23rd Apr 20204:04 pmRNSTransaction in Own Shares
22nd Apr 20205:35 pmRNSTransaction in Own Shares
21st Apr 20203:00 pmRNSTransaction in Own Shares
17th Apr 20205:13 pmRNSTransaction in Own Shares
15th Apr 20205:34 pmRNSTransaction in Own Shares
14th Apr 20207:00 amRNSAcquisition of ICI Insurance Company Limited
23rd Mar 20205:59 pmRNSTransaction in Own Shares
19th Mar 20204:52 pmRNSTransaction in Own Shares
19th Mar 20207:00 amRNSPart VII Transfer
18th Mar 20205:17 pmRNSTransaction in Own Shares
17th Mar 20205:43 pmRNSTransaction in Own Shares
17th Mar 20207:00 amRNSAccredited announces new underwriting program
16th Mar 20204:30 pmRNSTransaction in Own Shares
16th Mar 20207:00 amRNSShare Repurchase Programme
13th Mar 20207:00 amRNSR&Q and UK P&I Club agree transfer of liabilities
11th Feb 20208:00 amRNSProgram underwriting partnership
30th Jan 20207:00 amRNSPortfolio transfer
27th Jan 20207:00 amRNSAcquisition
16th Jan 20207:00 amRNSDirector Dealings
15th Jan 20207:00 amRNSDirectorate Change
14th Jan 20207:00 amRNSAllotment of Shares
13th Jan 20207:00 amRNSAppointment of Executive Deputy Chairman
30th Dec 201911:05 amRNSAcquisition
23rd Dec 20199:18 amRNSHolding(s) in Company
3rd Dec 20197:00 amRNSBoard Update
22nd Nov 201910:36 amRNSHolding(s) in Company
22nd Nov 20197:00 amRNSProgram underwriting partnership
28th Oct 20197:00 amRNSProgram underwriting partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.